Philips Respironics reaches agreement with US government on a consent decree creating a clear path forward
10. April 2024 02:05 ET
|
Royal Philips
April 10, 2024 Philips confirms that further to communicating the main terms of the Philips Respironics consent decree on January 29, 2024, Philips’ subsidiaries Philips Holding...
Philips reaches resolution of US economic loss litigation
07. September 2023 07:57 ET
|
Royal Philips
September 7, 2023 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) announced today that the company and certain of its US subsidiaries, including Philips Respironics, have reached an...
Philips provides update on completed set of test results for CPAP/BiPAP sleep therapy devices
16. Mai 2023 02:00 ET
|
Royal Philips
May 16, 2023 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG; AEX: PHIA), today provides an update on the comprehensive test and research program of its subsidiary Philips Respironics to...
Philips provides update on completed set of test results for first-generation DreamStation sleep therapy devices
21. Dezember 2022 02:00 ET
|
Royal Philips
December 21, 2022 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG; AEX: PHIA) today provides an update on the comprehensive test and research program of its subsidiary Philips...
Philips Respironics alerts customers worldwide of updated instructions and labeling of specific sleep therapy masks that contain magnetic headgear clips due to potential risk of serious injury
06. September 2022 16:00 ET
|
Royal Philips
September 6, 2022 These masks may continue to be used according to the updated instructions and labeling if patients or people in close proximity to them do not have implanted metallic medical...
Philips provides update on Philips Respironics’ PE-PUR sound abatement foam test and research program
28. Juni 2022 01:55 ET
|
Royal Philips
June 28, 2022 Testing in accordance with ISO 18562 and ISO 10993 standards conducted by five certified, independent testing laboratories in the US and Europe Amsterdam, the...
Philips Respironics issues voluntary recall notification/field safety notice* for the V60 ventilator product family
22. April 2022 11:00 ET
|
Royal Philips
April 22, 2022 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that its subsidiary Philips Respironics is notifying customers...
Philips Respironics provides update for the US on ongoing CPAP, BiPAP and Mechanical Ventilator field action
10. März 2022 19:15 ET
|
Royal Philips
March 10, 2022 Amsterdam, the Netherlands – Royal Philips’ (NYSE: PHG, AEX: PHIA) subsidiary, Philips Respironics, today provided an update on the remediation status in the US of the ongoing...
Philips provides update on the test and research program in connection with the CPAP, BiPAP and Mechanical Ventilator recall notification*
23. Dezember 2021 02:00 ET
|
Royal Philips
December 23, 2021 Amsterdam, the Netherlands – On June 14, 2021, Royal Philips’ (NYSE: PHG, AEX: PHIA) subsidiary, Philips Respironics, initiated a voluntary recall notification* for certain sleep...
Philips provides update on earlier announced voluntary CPAP, BiPAP and Mechanical Ventilator recall notification*
14. November 2021 05:00 ET
|
Royal Philips
November 14, 2021 Amsterdam, the Netherlands – On June 14, 2021, Royal Philips’ (NYSE: PHG, AEX: PHIA) subsidiary, Philips Respironics, initiated a voluntary recall notification* for certain...